Mayo Clinic Health System antibody treatments help prevent COVID hospitalizations

ROCHESTER, Minn. (WKBT) – A Mayo Clinic Health System study shows that two monoclonal antibody treatments reduce hospitalizations for high-risk COVID-19 patients.

The FDA has authorized the two treatments for emergency.

Nearly 1,400 Mayo patients were enrolled in the study between December and April.

Patients either received the treatment or a placebo.

The study found after four weeks hospitalizations were significantly lower in patients who received the treatments.

“In the setting of having COVID, we know now that this monoclonal antibody treatment is very effective,” physician in internal medicine Caroline Wilker said. “It’s very safe. We can confirm that it prevents hospitalizations if you’re at a higher risk.”

High risk patients include people 65 and older or who have underlying medical conditions.

If you have any questions about the treatments, Wilker says you should ask your healthcare provider.